Which agents threaten blood safety in the future?

Best Practice and Research: Clinical Haematology

Volumn 13, Issue 4, 2000, Pages 601-614

  Kitchen, Alan D ^a   Barbara, John A J ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Blood safety; GBV C; HHV8; SEN V; Transfusion transmitted infections; TTV; VCJD

Indexed keywords

ARTICLE; BLOOD EXAMINATION; BLOOD TRANSFUSION; CLINICAL MEDICINE; CONTAMINATION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE CONTROL; DISEASE TRANSMISSION; HEALTH SERVICE; HEPATITIS G VIRUS; HERPES VIRUS; HUMAN; INFECTION; MEDICAL EXAMINATION; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PUBLIC OPINION; SAFETY; SCREENING; TORQUE TENO VIRUS; VIROLOGY; VIRUS TRANSMISSION;

EID: 0034525787     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.2000.0102     Document Type: Article

References (61)

1. Reducing the risk of bacterial contamination of cellular blood components
2. A new variant of Creutzfeldt-Jakob disease in the UK
3. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
4. Can Creutzfeldt-Jakob disease be transmitted by transfusion?
5. PrP-dependent association of prions with splenic but not circulating lymphocytes of scrapie-infected mice
6. Three new human herpesviruses (HHV6, 7, and 8)
7. 'Cytomegalovirus disease' in renal allograft recipients: Is human herpesvirus 7 a co-factor for disease progression?
8. Correlation between the detection of viral DNA by the polymerase reaction in peripheral blood leukocytes and serological responses to human herpesvirus 6, human herpesvirus 7 and cytomegalovirus in renal allograft recipients
9. Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation
10. Identification of herpesvirus-like DNA sequences in AIDS- associated Kaposi's sarcoma
11. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients
12. Localisation of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma
13. Sexual transmission and the natural history of human herpesvirus 8 infection
14. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients
15. Infectious human herpesvirus 8 in a healthy North American blood donor
16. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
17. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
18. Human herpesvirus 8 (HHV8) serology in allogenic bone marrow transplant recipients
19. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay
20. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology
21. Molecular and biophysical characterization of TT virus: Evidence for a new virus family infecting humans
22. Faecal excretion of a non-enveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis
23. Detection of TT virus DNA in specimens other than blood
24. Distinct genotypes of a nonenveloped DNA virus associated with posttransfusion non-A to G hepatitis (TT virus) in plasma and peripheral blood mononuclear cells
25. Detection of TTV in peripheral blood mononuclear cells of intravenous drug users
26. Detection of a novel DNA virus in blood donors and blood products
27. TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis
28. Global distribution of transfusion-transmitted virus
29. Presence of a newly described human DNA virus (TTV) in patients with liver disease
30. Age-specific prevalence and transmission of TT virus
31. TTV materno-infantile infection - A study on the TTV frequency in Japanese pregnant women and the natural history of TTV mother-to-infant infection
32. TT virus infection in intravenous drug users
33. Transfusion transmitted virus
34. Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases
35. High prevalence and phylogenetic analysis of TT-virus infection in Mongolia
36. Prevalence of TT virus DNA in eastern Taiwan aborigines
37. High prevalence of TT virus infection in Japanese patients with liver diseases and in blood donors
38. TT virus infection in French hemodialysis patients: Study of prevalence and risk factors
39. Low risk of TT virus (TTV) infection in medical workers
40. High prevalence of TT virus (TTV) infection in patients on maintenance hemodialysis: Frequent mixed infections with different genotypes and lack of evidence of associated liver disease
41. Superinfection of TT virus and hepatitis C virus among chronic haemodialysis patients
42. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma
43. Clinical implications of coinfection with a novel DNA virus (TTV) in hepatitis C virus carriers on maintenance hemodialysis
44. Isolation of novel virus-like sequences associated with human hepatitis
45. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent
46. Prevalence of GB virus type C/hepatitis G virus RNA and of anti-E2 in individuals at high or low risk for blood-borne or sexually transmitted viruses: Evidence of sexual and parenteral transmission
47. GB virus type C viraemia and envelope antibodies among population subsets in the Netherlands
48. Prevalence of GB virus type C/hepatitis G virus RNA and anti-E2 among blood donors in Southeastern France
49. Detection of antibodies to a putative hepatitis G virus envelope protein
50. GB virus C (GBV-C/HGV) and E2 antibodies in children preliver and postliver transplant
51. Vertical transmission of hepatitis G
52. Intraspousal transmission of GB virus C/hepatitis G virus in an hepatitis C virus hyperendemic area in Japan
53. Is there evidence for vector transmission of GBV-C?
54. Prevalence of hepatitis G virus in a haemodialysis unit
55. Hepatitis G virus infection in lymphoma and in blood donors
56. GB virus-C/hepatitis G virus infection in Taiwan: A virus that fails to cause a disease?
57. GB virus type C infection in patients treated for childhood acute lymphoblastic leukemia
58. Transfusion-associated or nosocomial hepatitis G virus infection in patients undergoing surgery
59. A prospective study of transfusion-transmitted GB virus C infection: Similar frequency but different clinical presentation compared with hepatitis C virus
60. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease
61. Serum hepatitis G virus (HGV) RNA in multitransfused thalassemics from eastern Sicily